Bibliography

Found 109 results

Filters: Keyword is AIDS Dementia Complex [Clear All Filters]

1995

Yoshioka M, Bradley W, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava A, Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol. 1995 ;5(3):335-58.

1996

Shapshak P, Crandall KA, Xin KQ, Goodkin K, Fujimura RK, Bradley W, McCoy CB, Nagano I, Yoshioka M, Petito C, et al. HIV-1 neuropathogenesis and abused drugs: current reviews, problems, and solutions. Adv Exp Med Biol. 1996 ;402:171-86.

1998

Fujimura RK, Shapshak P, Segal DM, Crandall KA, Goodkin K, Page JB, Douyon R, Zhang BT, Xin KQ, P de la Vega R, et al. Viral and host determinants of neurovirulence of HIV-1 infection. Adv Exp Med Biol. 1998 ;437:241-53.

2006

Cosenza-Nashat MA, Kim MO, Zhao ML, Suh H-S, Lee SC. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathology (Zurich, Switzerland) [Internet]. 2006 ;16(4):256-65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107594

Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PNR, Molina R, Zheng W, Khamis I, Wilkie FL, et al. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Journal of NeuroVirology [Internet]. 2006 ;12(3):178-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877299

Everall I, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E. Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology [Internet]. 2006 ;67:1867-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17130427

Shapshak P, Duncan R, Nath A, Turchan-Cholewo J, Pandjassarame K, Rodriguez H, Duran EM, Ziegler F, Amaro E, Lewis A, et al. Gene chromosomal organization and expression in cultured human neurons exposed to cocaine and HIV-1 proteins gp120 and tat: drug abuse and NeuroAIDS. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2006 ;11:1774-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16368555

McArthur JC, Letendre SL. Is the glass three-quarters full or one-quarter empty?. J Infect Dis. 2006 ;194(12):1628-31.

Martin-Garcia J, Cao W, Varela-Rohena A, Plassmeyer ML, Gonzalez-Scarano F. HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor. Virology [Internet]. 2006 ;346:169-79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16309726

Wheeler EDA, Achim C, Ayyavoo V. Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients. Journal of Neurovirology [Internet]. 2006 ;12:200-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877301

Steiner J, Haughey NJ, Li W, Venkatesan A, Anderson C, Reid R, Malpica T, Pocernich CB, Butterfield DA, Nath A. Oxidative stress and therapeutic approaches in HIV dementia. Antioxidants & Redox Signaling [Internet]. 2006 ;8:2089-100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17034352

2007

Wang Y, White MG, Akay C, Chodroff RA, Robinson J, Lindl KA, Dichter MA, Qian Y, Mao Z, Kolson DL, et al. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J Neurochem. 2007 ;103(2):439-55.

Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745

Rosati A, Leone A, Del-Valle L, Amini S, Khalili K, Turco MC. Evidence for BAG3 modulation of HIV-1 gene transcription. Journal of Cellular Physiology [Internet]. 2007 ;210:676-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17187345

Woods SPaul, Carey C, Moran LM, Dawson MS, Letendre S, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2007 ;22:187-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17289343

Kumar A, Borodowsky I, Fernandez B, Gonzalez L, Kumar M. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. Journal of Neurovirology [Internet]. 2007 ;13:210-24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17613711

Letendre S, Ances BM, Gibson S, Ellis RJ. Neurologic complications of HIV disease and their treatment. Topics in HIV Medicine: A Publication of the International AIDS Society, USA [Internet]. 2007 ;15:32-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17485785

Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Journal of Neurovirology [Internet]. 2007 ;13:23-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17454445

Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA. Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)–2',3'-dideoxycytidine (ddC): relevance to HIV-dementia. Experimental Neurology [Internet]. 2007 ;204(1):29-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17069802

Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiology of Disease [Internet]. 2007 ;25(1):17-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17011204

2008

Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM. Cortical demyelination in PML and MS: Similarities and differences. Neurology [Internet]. 2008 ;70:336-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17914063

Robinson-Papp JS, Byrd D, Mindt MRivera, Oden NL, Simpson DM, Morgello S. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Archives of Neurology [Internet]. 2008 ;65:1096-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18695060

Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Nikbin B, Shapshak P. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Molecular Diagnosis & Therapy [Internet]. 2008 ;12:25-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18288880

Burdo TH, Ellis RJ, Fox HS. Osteopontin is increased in HIV-associated dementia. The Journal of Infectious Diseases [Internet]. 2008 ;198:715-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18616394

2009

Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, J McCutchan A, Simpson DM, Ellis R, et al. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.

Pages